Failure to Manage Diabetic Eye Disease Screenings Carries Staggering Costs
Diabetic retinopathy is a potentially blinding eye disease that affects 45% of Americans with diabetes. But turf battles between primary care providers and ophthalmologists and reticence from payers over screenings are racking up costs.
